Randi Hagerman

InstitutionUniversity of California Davis
AddressMIND Bldg/UCDMC
CA 95817
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Shelton AL, Wang JY, Fourie E, Tassone F, Chen A, Frizzi L, Hagerman R, Ferrer E, Hessl D, Rivera SM. Middle Cerebellar Peduncle Width-A Novel MRI Biomarker for FXTAS? Front Neurosci. 2018; 12:379. PMID: 29988561.
      View in: PubMed
    2. Ligsay A, El-Deeb M, Salcedo-Arellano MJ, Schloemerkemper N, Grayson JS, Hagerman R. General Anesthetic Use in Fragile X Spectrum Disorders. J Neurosurg Anesthesiol. 2018 May 04. PMID: 29734272.
      View in: PubMed
    3. Rajaratnam A, Shergill J, Salcedo-Arellano M, Saldarriaga W, Duan X, Hagerman R. Fragile X syndrome and fragile X-associated disorders. F1000Res. 2017; 6:2112. PMID: 29259781.
      View in: PubMed
    4. Sitzmann AF, Hagelstrom RT, Tassone F, Hagerman R, Butler MG. Rare FMR1 gene mutations causing fragile X syndrome: A review. Am J Med Genet A. 2018 Jan; 176(1):11-18. PMID: 29178241.
      View in: PubMed
    5. Jiraanont P, Kumar M, Tang HT, Espinal G, Hagerman PJ, Hagerman R, Chutabhakdikul N, Tassone F. Size and methylation mosaicism in males with Fragile X syndrome. Expert Rev Mol Diagn. 2017 Nov; 17(11):1023-1032. PMID: 28929824.
      View in: PubMed
    6. Hagerman R, Berry-Kravis E, Hazlett HC, Bailey DB, Moine H, Kooy RF, Tassone F, Gantois I, Sonenberg N, Mandel JL, Hagerman PJ. Fragile X syndrome. Nat Rev Dis Primers. 2017 Sep 29; 3:17065. PMID: 28960184.
      View in: PubMed
    7. McDuffie A, Banasik A, Bullard L, Nelson S, Feigles RT, Hagerman R, Abbeduto L. Distance delivery of a spoken language intervention for school-aged and adolescent boys with fragile X syndrome. Dev Neurorehabil. 2018 Jan; 21(1):48-63. PMID: 28956679.
      View in: PubMed
    8. Lechpammer M, Martínez Cerdeno V, Hunsaker MR, Hah M, Gonzales H, Tisch S, Joffe R, Pamphlett R, Tassone F, Hagerman PJ, Bolitho SJ, Hagerman R. Concomitant occurrence of FXTAS and clinically defined sporadic inclusion body myositis: report of two cases. Croat Med J. 2017 Aug 31; 58(4):310-315. PMID: 28857524.
      View in: PubMed
    9. Ligsay A, Van Dijck A, Nguyen DV, Lozano R, Chen Y, Bickel ES, Hessl D, Schneider A, Angkustsiri K, Tassone F, Ceulemans B, Kooy RF, Hagerman R. A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome. J Neurodev Disord. 2017 Aug 02; 9(1):26. PMID: 28764646.
      View in: PubMed
    10. Burris JL, Barry-Anwar RA, Sims RN, Hagerman R, Tassone F, Rivera SM. Children With Fragile X Syndrome Display Threat-Specific Biases Toward Emotion. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Sep; 2(6):487-492. PMID: 29348038.
      View in: PubMed
    11. Martínez-Cerdeño V, Lechpammer M, Hagerman PJ, Hagerman R. Two FMR1 premutation cases without nuclear inclusions. Mov Disord. 2017 Sep; 32(9):1328-1329. PMID: 28568317.
      View in: PubMed
    12. Bailey DB, Berry-Kravis E, Gane LW, Guarda S, Hagerman R, Powell CM, Tassone F, Wheeler A. Fragile X Newborn Screening: Lessons Learned From a Multisite Screening Study. Pediatrics. 2017 Jun; 139(Suppl 3):S216-S225. PMID: 28814542.
      View in: PubMed
    13. Wheeler A, Raspa M, Hagerman R, Mailick M, Riley C. Implications of the FMR1 Premutation for Children, Adolescents, Adults, and Their Families. Pediatrics. 2017 Jun; 139(Suppl 3):S172-S182. PMID: 28814538.
      View in: PubMed
    14. Nyquist PA, Hagerman R. Genetics, white matter, and cognition: The effects of methylation on FMR1. Neurology. 2017 May 30; 88(22):2070-2071. PMID: 28476761.
      View in: PubMed
    15. Wang JY, Hessl D, Hagerman R, Simon TJ, Tassone F, Ferrer E, Rivera SM. Abnormal trajectories in cerebellum and brainstem volumes in carriers of the fragile X premutation. Neurobiol Aging. 2017 Jul; 55:11-19. PMID: 28391068.
      View in: PubMed
    16. Boland MJ, Nazor KL, Tran HT, Szücs A, Lynch CL, Paredes R, Tassone F, Sanna PP, Hagerman R, Loring JF. Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome. Brain. 2017 Mar 01; 140(3):582-598. PMID: 28137726.
      View in: PubMed
    17. Thurman AJ, McDuffie A, Hagerman R, Josol CK, Abbeduto L. Language Skills of Males with Fragile X Syndrome or Nonsyndromic Autism Spectrum Disorder. J Autism Dev Disord. 2017 03; 47(3):728-743. PMID: 28074353.
      View in: PubMed
    18. Muzar Z, Lozano R, Kolevzon A, Hagerman R. The neurobiology of the Prader-Willi phenotype of fragile X syndrome. Intractable Rare Dis Res. 2016 Nov; 5(4):255-261. PMID: 27904820.
      View in: PubMed
    19. Lozano R, Saito N, Reed D, Eldeeb M, Schneider A, Hessl D, Tassone F, Beckett L, Hagerman R. Aging in Fragile X Premutation Carriers. Cerebellum. 2016 10; 15(5):587-94. PMID: 27334385.
      View in: PubMed
    20. Hall DA, Robertson E, Shelton AL, Losh MC, Mila M, Moreno EG, Gomez-Anson B, Martínez-Cerdeño V, Grigsby J, Lozano R, Hagerman R, Maria LS, Berry-Kravis E, O'Keefe JA. Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers. Cerebellum. 2016 10; 15(5):578-86. PMID: 27287737.
      View in: PubMed
    21. Greiss Hess L, Fitzpatrick SE, Nguyen DV, Chen Y, Gaul KN, Schneider A, Lemons Chitwood K, Eldeeb MA, Polussa J, Hessl D, Rivera S, Hagerman R. A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome. J Dev Behav Pediatr. 2016 Oct; 37(8):619-28. PMID: 27560971; PMCID: PMC5039060 [Available on 10/01/17].
    22. Napoli E, Song G, Wong S, Hagerman R, Giulivi C. Altered Bioenergetics in Primary Dermal Fibroblasts from Adult Carriers of the FMR1 Premutation Before the Onset of the Neurodegenerative Disease Fragile X-Associated Tremor/Ataxia Syndrome. Cerebellum. 2016 10; 15(5):552-64. PMID: 27089882.
      View in: PubMed
    23. Gossett A, Sansone S, Schneider A, Johnston C, Hagerman R, Tassone F, Rivera SM, Seritan AL, Hessl D. Psychiatric disorders among women with the?fragile X premutation without children affected by fragile X syndrome. Am J Med Genet B Neuropsychiatr Genet. 2016 12; 171(8):1139-1147. PMID: 27615674.
      View in: PubMed
    24. Giulivi C, Napoli E, Tassone F, Halmai J, Hagerman R. Plasma metabolic profile delineates roles for neurodegeneration, pro-inflammatory damage and mitochondrial dysfunction in the FMR1 premutation. Biochem J. 2016 11 01; 473(21):3871-3888. PMID: 27555610.
      View in: PubMed
    25. Ligsay A, Hagerman R. Review of targeted treatments in fragile X syndrome. Intractable Rare Dis Res. 2016 Aug; 5(3):158-67. PMID: 27672538; PMCID: PMC4995416.
    26. Salcedo-Arellano MJ, Lozano R, Tassone F, Hagerman R, Saldarriaga W. Alcohol use dependence in fragile X syndrome. Intractable Rare Dis Res. 2016 Aug; 5(3):207-13. PMID: 27672544; PMCID: PMC4995423.
    27. Lozano R, Azarang A, Wilaisakditipakorn T, Hagerman R. Fragile X syndrome: A review of clinical management. Intractable Rare Dis Res. 2016 Aug; 5(3):145-57. PMID: 27672537; PMCID: PMC4995426.
    28. Grigsby J, Brega AG, Bennett RE, Bourgeois JA, Seritan AL, Goodrich GK, Hagerman R. Clinically significant psychiatric symptoms among male carriers of the fragile X premutation, with and without FXTAS, and the mediating influence of executive functioning. Clin Neuropsychol. 2016 Aug; 30(6):944-59. PMID: 27355103; PMCID: PMC5011752 [Available on 08/01/17].
    29. Hagerman R, Hagerman P. Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management. Nat Rev Neurol. 2016 Jul; 12(7):403-12. PMID: 27340021.
      View in: PubMed
    30. Wang JY, Ngo MM, Hessl D, Hagerman R, Rivera SM. Robust Machine Learning-Based Correction on Automatic Segmentation of the Cerebellum and Brainstem. PLoS One. 2016; 11(5):e0156123. PMID: 27213683; PMCID: PMC4877064.
    31. Hagerman R. Psychopathology Increases With Age in Fragile X Carrier Mothers. Biol Psychiatry. 2016 05 15; 79(10):790-791. PMID: 27130851.
      View in: PubMed
    32. Yang JC, Rodriguez A, Royston A, Niu YQ, Avar M, Brill R, Simon C, Grigsby J, Hagerman R, Olichney JM. Memantine Improves Attentional Processes in Fragile X-Associated Tremor/Ataxia Syndrome: Electrophysiological Evidence from a Randomized Controlled Trial. Sci Rep. 2016 Feb 22; 6:21719. PMID: 26898832; PMCID: PMC4761982.
    33. Kazdoba TM, Hagerman R, Zolkowska D, Rogawski MA, Crawley JN. Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism. Psychopharmacology (Berl). 2016 Jan; 233(2):309-23. PMID: 26525567; PMCID: PMC4703522 [Available on 01/01/17].
    34. Martínez-Cerdeño V, Lechpammer M, Lott A, Schneider A, Hagerman R. Fragile X-Associated Tremor/Ataxia Syndrome in a Man in His 30s. JAMA Neurol. 2015 Sep; 72(9):1070-3. PMID: 26368352; PMCID: PMC4629842.
    35. Thurman AJ, McDuffie A, Kover ST, Hagerman R, Abbeduto L. Autism Symptomatology in Boys with Fragile X Syndrome: A Cross Sectional Developmental Trajectories Comparison with Nonsyndromic Autism Spectrum Disorder. J Autism Dev Disord. 2015 Sep; 45(9):2816-32. PMID: 25904201; PMCID: PMC4554893.
    36. Ram S, Devapriya IA, Fenton G, Mcvay L, Nguyen DV, Tassone F, Maselli RA, Hagerman R. Axonal neuropathy in female carriers of the fragile X premutation with fragile x-associated tremor ataxia syndrome. Muscle Nerve. 2015 Aug; 52(2):234-9. PMID: 25388402; PMCID: PMC4427531.
    37. Winarni TI, Schneider A, Ghaziuddin N, Seritan A, Hagerman R. Psychosis and catatonia in fragile X: Case report and literature review. Intractable Rare Dis Res. 2015 Aug; 4(3):139-46. PMID: 26361565; PMCID: PMC4561243.
    38. Godler DE, Inaba Y, Schwartz CE, Bui QM, Shi EZ, Li X, Herlihy AS, Skinner C, Hagerman R, Francis D, Amor DJ, Metcalfe SA, Hopper JL, Slater HR. Detection of skewed X-chromosome inactivation in Fragile X syndrome and X chromosome aneuploidy using quantitative melt analysis. Expert Rev Mol Med. 2015 Jul 01; 17:e13. PMID: 26132880; PMCID: PMC4836209.
    39. McDuffie A, Thurman AJ, Hagerman R, Abbeduto L. Symptoms of Autism in Males with Fragile X Syndrome: A Comparison to Nonsyndromic ASD Using Current ADI-R Scores. J Autism Dev Disord. 2015 Jul; 45(7):1925-37. PMID: 24414079; PMCID: PMC4096070.
    40. Basuta K, Schneider A, Gane L, Polussa J, Woodruff B, Pretto D, Hagerman R, Tassone F. High functioning male with fragile X syndrome and fragile X-associated tremor/ataxia syndrome. Am J Med Genet A. 2015 Sep; 167A(9):2154-61. PMID: 25920745.
      View in: PubMed
    41. Muzar Z, Lozano R, Schneider A, Adams PE, Faradz SM, Tassone F, Hagerman R. Methadone use in a male with the FMRI premutation and FXTAS. Am J Med Genet A. 2015 Jun; 167(6):1354-9. PMID: 25900641; PMCID: PMC4845901.
    42. Thurman AJ, McDuffie A, Kover ST, Hagerman R, Channell MM, Mastergeorge A, Abbeduto L. Use of emotional cues for lexical learning: a comparison of autism spectrum disorder and fragile X syndrome. J Autism Dev Disord. 2015 Apr; 45(4):1042-61. PMID: 25318904; PMCID: PMC4369166.
    43. Hagerman R, Polussa J. Treatment of the psychiatric problems associated with fragile X syndrome. Curr Opin Psychiatry. 2015 Mar; 28(2):107-12. PMID: 25602250.
      View in: PubMed
    44. Hagerman PJ, Hagerman R. Fragile X-associated tremor/ataxia syndrome. Ann N Y Acad Sci. 2015 Mar; 1338:58-70. PMID: 25622649; PMCID: PMC4363162.
    45. Lozano R, Martinez-Cerdeno V, Hagerman R. Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder. Curr Pharm Des. 2015; 21(34):4972-4979. PMID: 26365141; PMCID: PMC4830341.
    46. Saldarriaga W, Tassone F, González-Teshima LY, Forero-Forero JV, Ayala-Zapata S, Hagerman R. Fragile X syndrome. Colomb Med (Cali). 2014 Oct-Dec; 45(4):190-8. PMID: 25767309; PMCID: PMC4350386.
    47. Ariza J, Steward C, Rueckert F, Widdison M, Coffman R, Afjei A, Noctor SC, Hagerman R, Hagerman P, Martínez-Cerdeño V. Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome. Brain Res. 2015 Feb 19; 1598:88-96. PMID: 25498860; PMCID: PMC4340768.
    48. Jalnapurkar I, Rafika N, Tassone F, Hagerman R. Immune mediated disorders in women with a fragile X expansion and FXTAS. Am J Med Genet A. 2015 Jan; 167A(1):190-7. PMID: 25399540; PMCID: PMC4275322.
    49. Díez-Juan M, Schneider A, Phillips T, Lozano R, Tassone F, Solomon M, Hagerman R. Parent-delivered touchscreen intervention for children with fragile X syndrome. Intractable Rare Dis Res. 2014 Nov; 3(4):166-77. PMID: 25606367; PMCID: PMC4298647.
    50. Muzar Z, Adams PE, Schneider A, Hagerman R, Lozano R. Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases. Intractable Rare Dis Res. 2014 Nov; 3(4):162-5. PMID: 25606366; PMCID: PMC4298646.
    51. Chechi T, Siyahian S, Thairu L, Hagerman R, Lozano R. Participation of underrepresented minority children in clinical trials for Fragile X syndrome and other neurodevelopmental disorders. Intractable Rare Dis Res. 2014 Nov; 3(4):147-52. PMID: 25606364; PMCID: PMC4298644.
    52. Lozano R, Rosero CA, Hagerman R. Fragile X spectrum disorders. Intractable Rare Dis Res. 2014 Nov; 3(4):134-46. PMID: 25606363; PMCID: PMC4298643.
    53. Hanson AC, Hagerman R. Serotonin dysregulation in Fragile X Syndrome: implications for treatment. Intractable Rare Dis Res. 2014 Nov; 3(4):110-7. PMID: 25606361; PMCID: PMC4298641.
    54. Hagerman R, Lozano R, Schneider A. Translational research guided by animal studies in Fragile X Disorders. Intractable Rare Dis Res. 2014 Nov; 3(4):100. PMID: 25606359; PMCID: PMC4298639.
    55. Brick DJ, Nethercott HE, Montesano S, Banuelos MG, Stover AE, Schutte SS, O'Dowd DK, Hagerman R, Ono M, Hessl DR, Tassone F, Schwartz PH. The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery. Stem Cells Transl Med. 2014 Nov; 3(11):1275-86. PMID: 25273538; PMCID: PMC4214842.
    56. Lozano R, Hare EB, Hagerman R. Modulation of the GABAergic pathway for the treatment of fragile X syndrome. Neuropsychiatr Dis Treat. 2014; 10:1769-79. PMID: 25258535; PMCID: PMC4172237.
    57. Au J, Berkowitz-Sutherland L, Schneider A, Schweitzer JB, Hessl D, Hagerman R. A feasibility trial of Cogmed working memory training in fragile X syndrome. J Pediatr Genet. 2014 Sep; 3(3):147-56. PMID: 27625871; PMCID: PMC5021004.
    58. Yang JC, Chi L, Teichholtz S, Schneider A, Nanakul R, Nowacki R, Seritan A, Reed B, DeCarli C, Iragui VJ, Kutas M, Hagerman PJ, Hagerman R, Olichney JM. ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome (FXTAS) and amnestic MCI. Neuropsychologia. 2014 Oct; 63:34-42. PMID: 25111034; PMCID: PMC4194142.
    59. Tassone F, Hagerman PJ, Hagerman R. Fragile x premutation. J Neurodev Disord. 2014; 6(1):22. PMID: 25170346; PMCID: PMC4147873.
    60. Lozano R, Hagerman R, Duyzend M, Budimirovic DB, Eichler EE, Tassone F. Genomic studies in fragile X premutation carriers. J Neurodev Disord. 2014; 6(1):27. PMID: 25170347; PMCID: PMC4147387.
    61. Benjamin DP, Mastergeorge AM, McDuffie AS, Kover ST, Hagerman R, Abbeduto L. Effects of labeling and pointing on object gaze in boys with fragile X syndrome: an eye-tracking study. Res Dev Disabil. 2014 Nov; 35(11):2658-72. PMID: 25062097; PMCID: PMC4154990.
    62. Careaga M, Noyon T, Basuta K, Van de Water J, Tassone F, Hagerman R, Ashwood P. Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome. J Neuroinflammation. 2014 Jun 19; 11:110. PMID: 24942544.
      View in: PubMed
    63. Lozano R, Summers S, Lozano C, Mu Y, Hessl D, Nguyen D, Tassone F, Hagerman R. Association between macroorchidism and intelligence in FMR1 premutation carriers. Am J Med Genet A. 2014 Sep; 164A(9):2206-11. PMID: 24903624; PMCID: PMC4332881.
    64. Yang JC, Niu YQ, Simon C, Seritan AL, Chen L, Schneider A, Moghaddam ST, Hagerman PJ, Hagerman R, Olichney JM. Memantine effects on verbal memory in fragile X-associated tremor/ataxia syndrome (FXTAS): a double-blind brain potential study. Neuropsychopharmacology. 2014 Nov; 39(12):2760-8. PMID: 24871547; PMCID: PMC4200486.
    65. Careaga M, Rose D, Tassone F, Berman RF, Hagerman R, Ashwood P. Immune dysregulation as a cause of autoinflammation in fragile X premutation carriers: link between FMRI CGG repeat number and decreased cytokine responses. PLoS One. 2014; 9(4):e94475. PMID: 24718368.
      View in: PubMed
    66. Hagerman R, Des-Portes V, Gasparini F, Jacquemont S, Gomez-Mancilla B. Translating molecular advances in fragile X syndrome into therapy: a review. J Clin Psychiatry. 2014 Apr; 75(4):e294-307. PMID: 24813413.
      View in: PubMed
    67. Thurman AJ, McDuffie A, Hagerman R, Abbeduto L. Psychiatric symptoms in boys with fragile X syndrome: a comparison with nonsyndromic autism spectrum disorder. Res Dev Disabil. 2014 May; 35(5):1072-86. PMID: 24629733; PMCID: PMC4009990.
    68. Pretto DI, Mendoza-Morales G, Lo J, Cao R, Hadd A, Latham GJ, Durbin-Johnson B, Hagerman R, Tassone F. CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles. J Med Genet. 2014 May; 51(5):309-18. PMID: 24591415; PMCID: PMC4010431.
    69. Niu YQ, Yang JC, Hall DA, Leehey MA, Tassone F, Olichney JM, Hagerman R, Zhang L. Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited. Parkinsonism Relat Disord. 2014 Apr; 20(4):456-9. PMID: 24491663; PMCID: PMC4019503.
    70. Polussa J, Schneider A, Hagerman R. Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers. Brain Disord Ther. 2014; 3. PMID: 25436181.
      View in: PubMed
    71. Pretto DI, Kumar M, Cao Z, Cunningham CL, Durbin-Johnson B, Qi L, Berman R, Noctor SC, Hagerman R, Pessah IN, Tassone F. Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome. Neurobiol Aging. 2014 May; 35(5):1189-97. PMID: 24332449; PMCID: PMC4062976.
    72. Schneider A, Leigh MJ, Adams P, Nanakul R, Chechi T, Olichney J, Hagerman R, Hessl D. Electrocortical changes associated with minocycline treatment in fragile X syndrome. J Psychopharmacol. 2013 Oct; 27(10):956-63. PMID: 23981511; PMCID: PMC4962861.
    73. Yang JC, Simon C, Niu YQ, Bogost M, Schneider A, Tassone F, Seritan A, Grigsby J, Hagerman PJ, Hagerman R, Olichney JM. Phenotypes of hypofrontality in older female fragile X premutation carriers. Ann Neurol. 2013 Aug; 74(2):275-83. PMID: 23686745; PMCID: PMC3906211.
    74. Wang JY, Hessl D, Schneider A, Tassone F, Hagerman R, Rivera SM. Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles. JAMA Neurol. 2013 Aug; 70(8):1022-9. PMID: 23753897; PMCID: PMC4028037.
    75. Hagerman R, Hagerman P. Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol. 2013 Aug; 12(8):786-98. PMID: 23867198; PMCID: PMC3922535.
    76. Dziembowska M, Pretto DI, Janusz A, Kaczmarek L, Leigh MJ, Gabriel N, Durbin-Johnson B, Hagerman R, Tassone F. High MMP-9 activity levels in fragile X syndrome are lowered by minocycline. Am J Med Genet A. 2013 Aug; 161A(8):1897-903. PMID: 23824974.
      View in: PubMed
    77. McDuffie A, Kover ST, Hagerman R, Abbeduto L. Investigating word learning in fragile X syndrome: a fast-mapping study. J Autism Dev Disord. 2013 Jul; 43(7):1676-91. PMID: 23179343; PMCID: PMC3620772.
    78. Wang JY, Hagerman R, Rivera SM. A multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers. Mov Disord. 2013 Aug; 28(9):1278-84. PMID: 23649693; PMCID: PMC3785985.
    79. Leigh MJ, Nguyen DV, Mu Y, Winarni TI, Schneider A, Chechi T, Polussa J, Doucet P, Tassone F, Rivera SM, Hessl D, Hagerman R. A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome. J Dev Behav Pediatr. 2013 Apr; 34(3):147-55. PMID: 23572165; PMCID: PMC3706260.
    80. Seritan AL, Bourgeois JA, Schneider A, Mu Y, Hagerman R, Nguyen DV. Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers. Curr Psychiatry Rev. 2013 Feb; 9(1):65-71. PMID: 25844075.
      View in: PubMed
    81. Hagerman R. Epilepsy drives autism in neurodevelopmental disorders. Dev Med Child Neurol. 2013 Feb; 55(2):101-2. PMID: 23320573; PMCID: PMC4051495.
    82. Wadell PM, Hagerman R, Hessl DR. FRAGILE X SYNDROME: PSYCHIATRIC MANIFESTATIONS, ASSESSMENT AND EMERGING THERAPIES. Curr Psychiatry Rev. 2013 Feb 01; 9(1):53-58. PMID: 25632275.
      View in: PubMed
    83. Godler DE, Inaba Y, Shi EZ, Skinner C, Bui QM, Francis D, Amor DJ, Hopper JL, Loesch DZ, Hagerman R, Schwartz CE, Slater HR. Relationships between age and epi-genotype of the FMR1 exon 1/intron 1 boundary are consistent with non-random X-chromosome inactivation in FM individuals, with the selection for the unmethylated state being most significant between birth and puberty. Hum Mol Genet. 2013 Apr 15; 22(8):1516-24. PMID: 23307923; PMCID: PMC3605829.
    84. Schneider A, Ligsay A, Hagerman R. Fragile X syndrome: an aging perspective. Dev Disabil Res Rev. 2013; 18(1):68-74. PMID: 23949830; PMCID: PMC4959461.
    85. Seritan AL, Ortigas M, Seritan S, Bourgeois JA, Hagerman R. PSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS. Curr Psychiatry Rev. 2013; 9(1):59-64. PMID: 25620899.
      View in: PubMed
    86. Schneider A, Seritan A, Tassone F, Rivera SM, Hagerman R, Hessl D. Psychiatric features in high-functioning adult brothers with fragile x spectrum disorders. Prim Care Companion CNS Disord. 2013; 15(2). PMID: 23930232; PMCID: PMC3733525.
    87. Tassone F, Iong KP, Tong TH, Lo J, Gane LW, Berry-Kravis E, Nguyen D, Mu LY, Laffin J, Bailey DB, Hagerman R. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med. 2012; 4(12):100. PMID: 23259642; PMCID: PMC4064316.
    88. Sorensen PL, Gane LW, Yarborough M, Hagerman R, Tassone F. Newborn screening and cascade testing for FMR1 mutations. Am J Med Genet A. 2013 Jan; 161A(1):59-69. PMID: 23239591; PMCID: PMC3980469.
    89. Bagni C, Tassone F, Neri G, Hagerman R. Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. J Clin Invest. 2012 Dec; 122(12):4314-22. PMID: 23202739; PMCID: PMC3533539.
    90. Abrams L, Cronister A, Brown WT, Tassone F, Sherman SL, Finucane B, McConkie-Rosell A, Hagerman R, Kaufmann WE, Picker J, Coffey S, Skinner D, Johnson V, Miller R, Berry-Kravis E. Newborn, carrier, and early childhood screening recommendations for fragile X. Pediatrics. 2012 Dec; 130(6):1126-35. PMID: 23129072.
      View in: PubMed
    91. Inaba Y, Herlihy AS, Schwartz CE, Skinner C, Bui QM, Cobb J, Shi EZ, Francis D, Arvaj A, Amor DJ, Pope K, Wotton T, Cohen J, Hewitt JK, Hagerman R, Metcalfe SA, Hopper JL, Loesch DZ, Slater HR, Godler DE. Fragile X-related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study. Genet Med. 2013 Apr; 15(4):290-8. PMID: 23060046.
      View in: PubMed
    92. Gürkan CK, Hagerman R. TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME. Res Autism Spectr Disord. 2012 Oct 01; 6(4):1311-1320. PMID: 23162607.
      View in: PubMed
    93. Yang JC, Chan SH, Khan S, Schneider A, Nanakul R, Teichholtz S, Niu YQ, Seritan A, Tassone F, Grigsby J, Hagerman PJ, Hagerman R, Olichney JM. Neural substrates of executive dysfunction in fragile X-associated tremor/ataxia syndrome (FXTAS): a brain potential study. Cereb Cortex. 2013 Nov; 23(11):2657-66. PMID: 22918986; PMCID: PMC3792740.
    94. Winarni TI, Chonchaiya W, Sumekar TA, Ashwood P, Morales GM, Tassone F, Nguyen DV, Faradz SM, Van de Water J, Cook K, Hamlin A, Mu Y, Hagerman PJ, Hagerman R. Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet A. 2012 Oct; 158A(10):2473-81. PMID: 22903889; PMCID: PMC4105154.
    95. Indah Winarni T, Chonchaiya W, Adams E, Au J, Mu Y, Rivera SM, Nguyen DV, Hagerman R. Sertraline may improve language developmental trajectory in young children with fragile x syndrome: a retrospective chart review. Autism Res Treat. 2012; 2012:104317. PMID: 22934167; PMCID: PMC3420618.
    96. Liu J, Koscielska KA, Cao Z, Hulsizer S, Grace N, Mitchell G, Nacey C, Githinji J, McGee J, Garcia-Arocena D, Hagerman R, Nolta J, Pessah IN, Hagerman PJ. Signaling defects in iPSC-derived fragile X premutation neurons. Hum Mol Genet. 2012 Sep 01; 21(17):3795-805. PMID: 22641815; PMCID: PMC3412379.
    97. Hamlin AA, Sukharev D, Campos L, Mu Y, Tassone F, Hessl D, Nguyen DV, Loesch D, Hagerman R. Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS). Am J Med Genet A. 2012 Jun; 158A(6):1304-9. PMID: 22528549; PMCID: PMC3983689.
    98. Yrigollen CM, Durbin-Johnson B, Gane L, Nelson DL, Hagerman R, Hagerman PJ, Tassone F. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet Med. 2012 Aug; 14(8):729-36. PMID: 22498846; PMCID: PMC3990283.
    99. Sorensen PL, Basuta K, Mendoza-Morales G, Gane LW, Schneider A, Hagerman R, Tassone F. A fragile X sibship from a consanguineous family with a compound heterozygous female and partially methylated full mutation male. Am J Med Genet A. 2012 May; 158A(5):1221-4. PMID: 22488807; PMCID: PMC3331966.
    100. Wang JY, Hessl DH, Hagerman R, Tassone F, Rivera SM. Age-dependent structural connectivity effects in fragile x premutation. Arch Neurol. 2012 Apr; 69(4):482-9. PMID: 22491193; PMCID: PMC3979438.
    101. Cao Z, Hulsizer S, Tassone F, Tang HT, Hagerman R, Rogawski MA, Hagerman PJ, Pessah IN. Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. Hum Mol Genet. 2012 Jul 01; 21(13):2923-35. PMID: 22466801; PMCID: PMC3373240.
    102. Winarni TI, Schneider A, Borodyanskara M, Hagerman R. Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile x syndrome. Case Rep Genet. 2012; 2012:280813. PMID: 23074686; PMCID: PMC3447258.
    103. Hagerman R, Lauterborn J, Au J, Berry-Kravis E. Fragile X syndrome and targeted treatment trials. Results Probl Cell Differ. 2012; 54:297-335. PMID: 22009360; PMCID: PMC4114775.
    104. Loesch D, Hagerman R. Unstable mutations in the FMR1 gene and the phenotypes. Adv Exp Med Biol. 2012; 769:78-114. PMID: 23560306; PMCID: PMC4124039.
    105. Tassone F, Hagerman R. The fragile X-associated tremor ataxia syndrome. Results Probl Cell Differ. 2012; 54:337-57. PMID: 22009361.
      View in: PubMed
    106. Sumekar TA, Ashrani AA, Winarni TI, Hagerman R. Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Man with Fragile X-associated Tremor/Ataxia Syndrome. Case Rep Genet. 2011; 2011:143132. PMID: 23074671; PMCID: PMC3447231.
    107. Selmeczy D, Koldewyn K, Wang JM, Lee A, Harvey D, Hessl DR, Tassone F, Adams P, Hagerman R, Hagerman PJ, Rivera SM. Investigation of amygdala volume in men with the fragile X premutation. Brain Imaging Behav. 2011 Dec; 5(4):285-94. PMID: 21786216; PMCID: PMC3982607.
    108. Hagerman R. The fragile X-associated disorders: time to order fragile X DNA testing. Biol Psychiatry. 2011 Nov 01; 70(9):802-3. PMID: 21986091.
      View in: PubMed
    109. Chonchaiya W, Au J, Schneider A, Hessl D, Harris SW, Laird M, Mu Y, Tassone F, Nguyen DV, Hagerman R. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Hum Genet. 2012 Apr; 131(4):581-9. PMID: 22001913; PMCID: PMC4105134.
    110. Hamlin A, Liu Y, Nguyen DV, Tassone F, Zhang L, Hagerman R. Sleep apnea in fragile X premutation carriers with and without FXTAS. Am J Med Genet B Neuropsychiatr Genet. 2011 Dec; 156B(8):923-8. PMID: 21932336; PMCID: PMC4109408.
    111. Leehey MA, Legg W, Tassone F, Hagerman R. Fibromyalgia in fragile X mental retardation 1 gene premutation carriers. Rheumatology (Oxford). 2011 Dec; 50(12):2233-6. PMID: 21926154; PMCID: PMC3222847.
    112. Stöger R, Genereux DP, Hagerman R, Hagerman PJ, Tassone F, Laird CD. Testing the FMR1 promoter for mosaicism in DNA methylation among CpG sites, strands, and cells in FMR1-expressing males with fragile X syndrome. PLoS One. 2011; 6(8):e23648. PMID: 21909353; PMCID: PMC3166088.
    113. Hunsaker MR, Greco CM, Spath MA, Smits AP, Navarro CS, Tassone F, Kros JM, Severijnen LA, Berry-Kravis EM, Berman RF, Hagerman PJ, Willemsen R, Hagerman R, Hukema RK. Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice. Acta Neuropathol. 2011 Oct; 122(4):467-79. PMID: 21785977; PMCID: PMC3222079.
    114. Hunsaker MR, Greco CM, Tassone F, Berman RF, Willemsen R, Hagerman R, Hagerman PJ. Rare intranuclear inclusions in the brains of 3 older adult males with fragile x syndrome: implications for the spectrum of fragile x-associated disorders. J Neuropathol Exp Neurol. 2011 Jun; 70(6):462-9. PMID: 21572337; PMCID: PMC3109086.
    115. Hagerman R, Au J, Hagerman P. FMR1 premutation and full mutation molecular mechanisms related to autism. J Neurodev Disord. 2011 Sep; 3(3):211-24. PMID: 21617890; PMCID: PMC3261276.
    116. Napoli E, Ross-Inta C, Wong S, Omanska-Klusek A, Barrow C, Iwahashi C, Garcia-Arocena D, Sakaguchi D, Berry-Kravis E, Hagerman R, Hagerman PJ, Giulivi C. Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome. Hum Mol Genet. 2011 Aug 01; 20(15):3079-92. PMID: 21558427; PMCID: PMC3131047.
    117. Narcisa V, Aguilar D, Nguyen DV, Campos L, Brodovsky J, White S, Adams P, Tassone F, Hagerman PJ, Hagerman R. A Quantitative Assessment of Tremor and Ataxia in Female FMR1 Premutation Carriers Using CATSYS. Curr Gerontol Geriatr Res. 2011; 2011:484713. PMID: 23008705; PMCID: PMC3114433.
    118. McLennan Y, Polussa J, Tassone F, Hagerman R. Fragile x syndrome. Curr Genomics. 2011 May; 12(3):216-24. PMID: 22043169; PMCID: PMC3137006.
    119. Hashimoto R, Srivastava S, Tassone F, Hagerman R, Rivera SM. Diffusion tensor imaging in male premutation carriers of the fragile X mental retardation gene. Mov Disord. 2011 Jun; 26(7):1329-36. PMID: 21484870; PMCID: PMC3119762.
    120. Zhang L, Sukharev D, Schneider A, Olichney JM, Seritan A, Hagerman R. Case report: Dystonia in a fragile X carrier. Mov Disord. 2014 Jun; 29(7):E4-5. PMID: 21469199; PMCID: PMC3136610.
    121. Hashimoto R, Javan AK, Tassone F, Hagerman R, Rivera SM. A voxel-based morphometry study of grey matter loss in fragile X-associated tremor/ataxia syndrome. Brain. 2011 Mar; 134(Pt 3):863-78. PMID: 21354978; PMCID: PMC3044831.
    122. Basuta K, Narcisa V, Chavez A, Kumar M, Gane L, Hagerman R, Tassone F. Clinical phenotypes of a juvenile sibling pair carrying the fragile X premutation. Am J Med Genet A. 2011 Mar; 155A(3):519-25. PMID: 21344625; PMCID: PMC3568664.
    123. Greco CM, Navarro CS, Hunsaker MR, Maezawa I, Shuler JF, Tassone F, Delany M, Au JW, Berman RF, Jin LW, Schumann C, Hagerman PJ, Hagerman R. Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome. Mol Autism. 2011 Feb 08; 2(1):2. PMID: 21303513; PMCID: PMC3045897.
    124. Jacquemont S, Curie A, des Portes V, Torrioli MG, Berry-Kravis E, Hagerman R, Ramos FJ, Cornish K, He Y, Paulding C, Neri G, Chen F, Hadjikhani N, Martinet D, Meyer J, Beckmann JS, Delange K, Brun A, Bussy G, Gasparini F, Hilse T, Floesser A, Branson J, Bilbe G, Johns D, Gomez-Mancilla B. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med. 2011 Jan 05; 3(64):64ra1. PMID: 21209411.
      View in: PubMed
    125. Gane LW, Iosif AM, Flynn-Wilson L, Venturino M, Hagerman R, Seritan AL. Assessment of patient and caregiver needs in fragile X-associated tremor/ataxia syndrome by utilizing Q-sort methodology. Aging Ment Health. 2010 Nov; 14(8):1000-7. PMID: 21069606; PMCID: PMC3189491.
    126. Schneider A, Ballinger E, Chavez A, Tassone F, Hagerman R, Hessl D. Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome. Neurobiol Aging. 2012 Jun; 33(6):1045-53. PMID: 20961665; PMCID: PMC3044775.
    127. Ortigas MC, Bourgeois JA, Schneider A, Olichney J, Nguyen DV, Cogswell JB, Hall DA, Hagerman R. Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine. J Clin Psychopharmacol. 2010 Oct; 30(5):642-4. PMID: 20841969; PMCID: PMC4022473.
    128. Hagerman R, Hoem G, Hagerman P. Fragile X and autism: Intertwined at the molecular level leading to targeted treatments. Mol Autism. 2010 Sep 21; 1(1):12. PMID: 20858229; PMCID: PMC2954865.
    129. Chonchaiya W, Tassone F, Ashwood P, Hessl D, Schneider A, Campos L, Nguyen DV, Hagerman R. Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome. Hum Genet. 2010 Nov; 128(5):539-48. PMID: 20809278; PMCID: PMC2955238.
    130. Bourgeois JA, Seritan AL, Casillas EM, Hessl D, Schneider A, Yang Y, Kaur I, Cogswell JB, Nguyen DV, Hagerman R. Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. J Clin Psychiatry. 2011 Feb; 72(2):175-82. PMID: 20816038; PMCID: PMC4038118.
    131. Ross-Inta C, Omanska-Klusek A, Wong S, Barrow C, Garcia-Arocena D, Iwahashi C, Berry-Kravis E, Hagerman R, Hagerman PJ, Giulivi C. Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome. Biochem J. 2010 Aug 01; 429(3):545-52. PMID: 20513237; PMCID: PMC4011071.
    132. Wang LW, Berry-Kravis E, Hagerman R. Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics. 2010 Jul; 7(3):264-74. PMID: 20643379; PMCID: PMC4084556.
    133. Hashimoto R, Backer KC, Tassone F, Hagerman R, Rivera SM. An fMRI study of the prefrontal activity during the performance of a working memory task in premutation carriers of the fragile X mental retardation 1 gene with and without fragile X-associated tremor/ataxia syndrome (FXTAS). J Psychiatr Res. 2011 Jan; 45(1):36-43. PMID: 20537351; PMCID: PMC2978252.
    134. Paul R, Pessah IN, Gane L, Ono M, Hagerman PJ, Brunberg JA, Tassone F, Bourgeois JA, Adams PE, Nguyen DV, Hagerman R. Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxins. Neurotoxicology. 2010 Aug; 31(4):399-402. PMID: 20466021; PMCID: PMC3918243.
    135. Godler DE, Tassone F, Loesch DZ, Taylor AK, Gehling F, Hagerman R, Burgess T, Ganesamoorthy D, Hennerich D, Gordon L, Evans A, Choo KH, Slater HR. Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. Hum Mol Genet. 2010 Apr 15; 19(8):1618-32. PMID: 20118148; PMCID: PMC2846165.
    136. Yuhas J, Walichiewicz P, Pan R, Zhang W, Casillas EM, Hagerman R, Tassone F. High-risk fragile x screening in Guatemala: use of a new blood spot polymerase chain reaction technique. Genet Test Mol Biomarkers. 2009 Dec; 13(6):855-9. PMID: 19810826; PMCID: PMC2935836.
    137. Seritan AL, Schneider A, Olichney JM, Leehey MA, Akins RS, Hagerman R. Conversion disorder in women with the FMR1 premutation. Am J Med Genet A. 2009 Nov; 149A(11):2501-6. PMID: 19842197; PMCID: PMC2783547.
    138. Garcia-Arocena D, Yang JE, Brouwer JR, Tassone F, Iwahashi C, Berry-Kravis EM, Goetz CG, Sumis AM, Zhou L, Nguyen DV, Campos L, Howell E, Ludwig A, Greco C, Willemsen R, Hagerman R, Hagerman PJ. Fibroblast phenotype in male carriers of FMR1 premutation alleles. Hum Mol Genet. 2010 Jan 15; 19(2):299-312. PMID: 19864489; PMCID: PMC2796892.
    139. Iwahashi C, Tassone F, Hagerman R, Yasui D, Parrott G, Nguyen D, Mayeur G, Hagerman PJ. A quantitative ELISA assay for the fragile x mental retardation 1 protein. J Mol Diagn. 2009 Jul; 11(4):281-9. PMID: 19460937; PMCID: PMC2710703.
    140. Bourgeois JA, Coffey SM, Rivera SM, Hessl D, Gane LW, Tassone F, Greco C, Finucane B, Nelson L, Berry-Kravis E, Grigsby J, Hagerman PJ, Hagerman R. A review of fragile X premutation disorders: expanding the psychiatric perspective. J Clin Psychiatry. 2009 Jun; 70(6):852-62. PMID: 19422761; PMCID: PMC2705685.
    141. Wirojanan J, Jacquemont S, Diaz R, Bacalman S, Anders TF, Hagerman R, Goodlin-Jones BL. The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. J Clin Sleep Med. 2009 Apr 15; 5(2):145-50. PMID: 19968048; PMCID: PMC2670334.
    142. Sentürk D, Nguyen DV, Tassone F, Hagerman R, Carroll RJ, Hagerman PJ. Covariate adjusted correlation analysis with application to FMR1 premutation female carrier data. Biometrics. 2009 Sep; 65(3):781-92. PMID: 19173699; PMCID: PMC2748149.
    143. Chonchaiya W, Schneider A, Hagerman R. Fragile X: a family of disorders. Adv Pediatr. 2009; 56:165-86. PMID: 19968948; PMCID: PMC2921504.
    144. Hagerman R, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, Kronk R, Delahunty C, Hessl D, Visootsak J, Picker J, Gane L, Tranfaglia M. Advances in the treatment of fragile X syndrome. Pediatrics. 2009 Jan; 123(1):378-90. PMID: 19117905; PMCID: PMC2888470.
    145. Cornish KM, Kogan CS, Li L, Turk J, Jacquemont S, Hagerman R. Lifespan changes in working memory in fragile X premutation males. Brain Cogn. 2009 Apr; 69(3):551-8. PMID: 19114290; PMCID: PMC4158922.
    146. Hagerman R, Hagerman PJ. Testing for fragile X gene mutations throughout the life span. JAMA. 2008 Nov 26; 300(20):2419-21. PMID: 19033593; PMCID: PMC2766594.
    147. Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I, Tassone F, Hagerman PJ, Herman H, Hagerman R. Autism profiles of males with fragile X syndrome. Am J Ment Retard. 2008 Nov; 113(6):427-38. PMID: 19127654.
      View in: PubMed
    148. Kogan CS, Turk J, Hagerman R, Cornish KM. Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome: a controlled study. Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 05; 147B(6):859-72. PMID: 18165971.
      View in: PubMed
    149. Greco CM, Tassone F, Garcia-Arocena D, Tartaglia N, Coffey SM, Vartanian TK, Brunberg JA, Hagerman PJ, Hagerman R. Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis. Arch Neurol. 2008 Aug; 65(8):1114-6. PMID: 18695063; PMCID: PMC3081275.
    150. Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, Bronsky HE, Yuhas J, Borodyanskaya M, Grigsby J, Doerflinger M, Hagerman PJ, Hagerman R. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A. 2008 Apr 15; 146A(8):1009-16. PMID: 18348275; PMCID: PMC2888464.
    151. Soontarapornchai K, Maselli R, Fenton-Farrell G, Tassone F, Hagerman PJ, Hessl D, Hagerman R. Abnormal nerve conduction features in fragile X premutation carriers. Arch Neurol. 2008 Apr; 65(4):495-8. PMID: 18413472; PMCID: PMC2888466.
    152. Wirojanan J, Angkustsiri K, Tassone F, Gane LW, Hagerman R. A girl with fragile X premutation from sperm donation. Am J Med Genet A. 2008 Apr 01; 146A(7):888-92. PMID: 18286596.
      View in: PubMed
    153. Aguilar D, Sigford KE, Soontarapornchai K, Nguyen DV, Adams PE, Yuhas JM, Tassone F, Hagerman PJ, Hagerman R. A quantitative assessment of tremor and ataxia in FMR1 premutation carriers using CATSYS. Am J Med Genet A. 2008 Mar 01; 146A(5):629-35. PMID: 18241072.
      View in: PubMed
    154. Wirojanan J, Kraff J, Hawkins DS, Laird C, Gane LW, Angkustsiri K, Tassone F, Hagerman R. Two boys with fragile x syndrome and hepatic tumors. J Pediatr Hematol Oncol. 2008 Mar; 30(3):239-41. PMID: 18376289.
      View in: PubMed
    155. Grigsby J, Brega AG, Engle K, Leehey MA, Hagerman R, Tassone F, Hessl D, Hagerman PJ, Cogswell JB, Bennett RE, Cook K, Hall DA, Bounds LS, Paulich MJ, Reynolds A. Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. Neuropsychology. 2008 Jan; 22(1):48-60. PMID: 18211155.
      View in: PubMed
    156. Hagerman R, Hall DA, Coffey S, Leehey M, Bourgeois J, Gould J, Zhang L, Seritan A, Berry-Kravis E, Olichney J, Miller JW, Fong AL, Carpenter R, Bodine C, Gane LW, Rainin E, Hagerman H, Hagerman PJ. Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. Clin Interv Aging. 2008; 3(2):251-62. PMID: 18686748; PMCID: PMC2546470.
    157. Cornish KM, Li L, Kogan CS, Jacquemont S, Turk J, Dalton A, Hagerman R, Hagerman PJ. Age-dependent cognitive changes in carriers of the fragile X syndrome. Cortex. 2008 Jun; 44(6):628-36. PMID: 18472033.
      View in: PubMed
    158. Hagerman R, Coffey SM, Maselli R, Soontarapornchai K, Brunberg JA, Leehey MA, Zhang L, Gane LW, Fenton-Farrell G, Tassone F, Hagerman PJ. Neuropathy as a presenting feature in fragile X-associated tremor/ataxia syndrome. Am J Med Genet A. 2007 Oct 01; 143A(19):2256-60. PMID: 17726686.
      View in: PubMed
    159. McConkie-Rosell A, Abrams L, Finucane B, Cronister A, Gane LW, Coffey SM, Sherman S, Nelson LM, Berry-Kravis E, Hessl D, Chiu S, Street N, Vatave A, Hagerman R. Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders. J Genet Couns. 2007 Oct; 16(5):593-606. PMID: 17497108.
      View in: PubMed
    160. Grigsby J, Brega AG, Leehey MA, Goodrich GK, Jacquemont S, Loesch DZ, Cogswell JB, Epstein J, Wilson R, Jardini T, Gould E, Bennett RE, Hessl D, Cohen S, Cook K, Tassone F, Hagerman PJ, Hagerman R. Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndrome. Mov Disord. 2007 Apr 15; 22(5):645-50. PMID: 17266074.
      View in: PubMed
    161. Solomon M, Hessl D, Chiu S, Hagerman R, Hendren R. A genetic etiology of pervasive developmental disorder guides treatment. Am J Psychiatry. 2007 Apr; 164(4):575-80. PMID: 17403969.
      View in: PubMed
    162. Nowicki ST, Tassone F, Ono MY, Ferranti J, Croquette MF, Goodlin-Jones B, Hagerman R. The Prader-Willi phenotype of fragile X syndrome. J Dev Behav Pediatr. 2007 Apr; 28(2):133-8. PMID: 17435464.
      View in: PubMed
    163. Hessl D, Tassone F, Cordeiro L, Koldewyn K, McCormick C, Green C, Wegelin J, Yuhas J, Hagerman R. Brief report: aggression and stereotypic behavior in males with fragile X syndrome--moderating secondary genes in a "single gene" disorder. J Autism Dev Disord. 2008 Jan; 38(1):184-9. PMID: 17340199.
      View in: PubMed
    164. Leehey MA, Hagerman R, Hagerman PJ. Fragile X syndrome vs fragile X-associated tremor/ataxia syndrome. Arch Neurol. 2007 Feb; 64(2):289; author reply 289-90. PMID: 17296852.
      View in: PubMed
    165. Chiu S, Wegelin JA, Blank J, Jenkins M, Day J, Hessl D, Tassone F, Hagerman R. Early acceleration of head circumference in children with fragile x syndrome and autism. J Dev Behav Pediatr. 2007 Feb; 28(1):31-5. PMID: 17353729.
      View in: PubMed
    166. Hagerman PJ, Hagerman R. Fragile X-associated tremor/ataxia syndrome--an older face of the fragile X gene. Nat Clin Pract Neurol. 2007 Feb; 3(2):107-12. PMID: 17279084.
      View in: PubMed
    167. Jacquemont S, Hagerman R, Hagerman PJ, Leehey MA. Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. Lancet Neurol. 2007 Jan; 6(1):45-55. PMID: 17166801.
      View in: PubMed
    168. Berry-Kravis E, Goetz CG, Leehey MA, Hagerman R, Zhang L, Li L, Nguyen D, Hall DA, Tartaglia N, Cogswell J, Tassone F, Hagerman PJ. Neuropathic features in fragile X premutation carriers. Am J Med Genet A. 2007 Jan 01; 143A(1):19-26. PMID: 17152065.
      View in: PubMed
    169. Hessl D, Rivera S, Koldewyn K, Cordeiro L, Adams J, Tassone F, Hagerman PJ, Hagerman R. Amygdala dysfunction in men with the fragile X premutation. Brain. 2007 Feb; 130(Pt 2):404-16. PMID: 17166860.
      View in: PubMed
    170. Loesch DZ, Bui QM, Dissanayake C, Clifford S, Gould E, Bulhak-Paterson D, Tassone F, Taylor AK, Hessl D, Hagerman R, Huggins RM. Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X. Neurosci Biobehav Rev. 2007; 31(3):315-26. PMID: 17097142; PMCID: PMC2145511.
    171. Wittenberger MD, Hagerman R, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL, Nelson LM. The FMR1 premutation and reproduction. Fertil Steril. 2007 Mar; 87(3):456-65. PMID: 17074338.
      View in: PubMed
    172. Loesch DZ, Bui QM, Huggins RM, Mitchell RJ, Hagerman R, Tassone F. Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats. J Med Genet. 2007 Mar; 44(3):200-4. PMID: 16905681; PMCID: PMC2598026.
    173. Jacquemont S, Leehey MA, Hagerman R, Beckett LA, Hagerman PJ. Size bias of fragile X premutation alleles in late-onset movement disorders. J Med Genet. 2006 Oct; 43(10):804-9. PMID: 16723388; PMCID: PMC2563171.
    174. Hagerman R. Lessons from fragile X regarding neurobiology, autism, and neurodegeneration. J Dev Behav Pediatr. 2006 Feb; 27(1):63-74. PMID: 16511373.
      View in: PubMed
    175. Bourgeois JA, Farzin F, Brunberg JA, Tassone F, Hagerman P, Zhang L, Hessl D, Hagerman R. Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine. J Neuropsychiatry Clin Neurosci. 2006; 18(2):171-7. PMID: 16720793.
      View in: PubMed
    176. Bacalman S, Farzin F, Bourgeois JA, Cogswell J, Goodlin-Jones BL, Gane LW, Grigsby J, Leehey MA, Tassone F, Hagerman R. Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. J Clin Psychiatry. 2006 Jan; 67(1):87-94. PMID: 16426093.
      View in: PubMed
    177. Hessl D, Tassone F, Loesch DZ, Berry-Kravis E, Leehey MA, Gane LW, Barbato I, Rice C, Gould E, Hall DA, Grigsby J, Wegelin JA, Harris S, Lewin F, Weinberg D, Hagerman PJ, Hagerman R. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 05; 139B(1):115-21. PMID: 16184602.
      View in: PubMed
    178. Hagerman R, Ono MY, Hagerman PJ. Recent advances in fragile X: a model for autism and neurodegeneration. Curr Opin Psychiatry. 2005 Sep; 18(5):490-6. PMID: 16639106.
      View in: PubMed
    179. Schwartz PH, Tassone F, Greco CM, Nethercott HE, Ziaeian B, Hagerman R, Hagerman PJ. Neural progenitor cells from an adult patient with fragile X syndrome. BMC Med Genet. 2005 Jan 14; 6:2. PMID: 15649335; PMCID: PMC545950.
    180. Mothersead PK, Conrad K, Hagerman R, Greco CM, Hessl D, Tassone F. GRAND ROUNDS: an atypical progressive dementia in a male carrier of the fragile X premutation: an example of fragile X-associated tremor/ataxia syndrome. Appl Neuropsychol. 2005; 12(3):169-78. PMID: 16131344.
      View in: PubMed
    181. Goodlin-Jones BL, Tassone F, Gane LW, Hagerman R. Autistic spectrum disorder and the fragile X premutation. J Dev Behav Pediatr. 2004 Dec; 25(6):392-8. PMID: 15613987.
      View in: PubMed
    182. Moore CJ, Daly EM, Tassone F, Tysoe C, Schmitz N, Ng V, Chitnis X, McGuire P, Suckling J, Davies KE, Hagerman R, Hagerman PJ, Murphy KC, Murphy DG. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy. Brain. 2004 Dec; 127(Pt 12):2672-81. PMID: 15483045.
      View in: PubMed
    183. Zeesman S, Zwaigenbaum L, Whelan DT, Hagerman R, Tassone F, Taylor SA. Paternal transmission of fragile X syndrome. Am J Med Genet A. 2004 Aug 30; 129A(2):184-9. PMID: 15316964.
      View in: PubMed
    184. Hagerman PJ, Hagerman R. The fragile-X premutation: a maturing perspective. Am J Hum Genet. 2004 May; 74(5):805-16. PMID: 15052536; PMCID: PMC1181976.
    185. Jacquemont S, Hagerman R, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJ. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA. 2004 Jan 28; 291(4):460-9. PMID: 14747503.
      View in: PubMed
    186. Hagerman PJ, Hagerman R. Fragile X-associated tremor/ataxia syndrome (FXTAS). Ment Retard Dev Disabil Res Rev. 2004; 10(1):25-30. PMID: 14994285.
      View in: PubMed
    187. Loesch DZ, Huggins RM, Hagerman R. Phenotypic variation and FMRP levels in fragile X. Ment Retard Dev Disabil Res Rev. 2004; 10(1):31-41. PMID: 14994286.
      View in: PubMed
    188. Crnic LS, Hagerman R. Preface: fragile X syndrome: frontiers of understanding gene-brain-behavior relationships. Ment Retard Dev Disabil Res Rev. 2004; 10(1):1-2. PMID: 14994281.
      View in: PubMed
    189. Moore CJ, Daly EM, Schmitz N, Tassone F, Tysoe C, Hagerman R, Hagerman PJ, Morris RG, Murphy KC, Murphy DG. A neuropsychological investigation of male premutation carriers of fragile X syndrome. Neuropsychologia. 2004; 42(14):1934-47. PMID: 15381024.
      View in: PubMed
    190. Loesch DZ, Bui QM, Grigsby J, Butler E, Epstein J, Huggins RM, Taylor AK, Hagerman R. Effect of the fragile X status categories and the fragile X mental retardation protein levels on executive functioning in males and females with fragile X. Neuropsychology. 2003 Oct; 17(4):646-57. PMID: 14599277.
      View in: PubMed
    191. Jacquemont S, Hagerman R, Leehey M, Grigsby J, Zhang L, Brunberg JA, Greco C, Des Portes V, Jardini T, Levine R, Berry-Kravis E, Brown WT, Schaeffer S, Kissel J, Tassone F, Hagerman PJ. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet. 2003 Apr; 72(4):869-78. PMID: 12638084; PMCID: PMC1180350.
    192. Loesch DZ, Huggins RM, Bui QM, Epstein JL, Taylor AK, Hagerman R. Effect of the deficits of fragile X mental retardation protein on cognitive status of fragile x males and females assessed by robust pedigree analysis. J Dev Behav Pediatr. 2002 Dec; 23(6):416-23. PMID: 12476071.
      View in: PubMed
    193. Primerano B, Tassone F, Hagerman R, Hagerman P, Amaldi F, Bagni C. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA. 2002 Dec; 8(12):1482-8. PMID: 12515381; PMCID: PMC1370354.
    194. Brunberg JA, Jacquemont S, Hagerman R, Berry-Kravis EM, Grigsby J, Leehey MA, Tassone F, Brown WT, Greco CM, Hagerman PJ. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am J Neuroradiol. 2002 Nov-Dec; 23(10):1757-66. PMID: 12427636.
      View in: PubMed
    195. Hagerman R, Hagerman PJ. The fragile X premutation: into the phenotypic fold. Curr Opin Genet Dev. 2002 Jun; 12(3):278-83. PMID: 12076670.
      View in: PubMed
    196. Hagerman R, Miller LJ, McGrath-Clarke J, Riley K, Goldson E, Harris SW, Simon J, Church K, Bonnell J, Ognibene TC, McIntosh DN. Influence of stimulants on electrodermal studies in Fragile X syndrome. Microsc Res Tech. 2002 May 01; 57(3):168-73. PMID: 12112453.
      View in: PubMed